Steven Chaussy's most recent trade in Biosig Technologies Inc was a trade of 11,425 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Sept. 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biosig Technologies Inc | Steven Chaussy | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 01 Sep 2022 | 11,425 | 1,051,553 (4%) | 0% | 1.1 | 12,929 | Common Stock |
| Biosig Technologies Inc | Steven Chaussy | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 22 Aug 2022 | 8,000 | 1,040,128 (4%) | 0% | 1.1 | 9,016 | Common Stock |
| Biosig Technologies Inc | Steven Chaussy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 200,000 | 200,000 | - | - | Restricted Stock | |
| Biosig Technologies Inc | Steven Chaussy | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 21 May 2021 | 1,000 | 833,128 (3%) | 0% | 3.4 | 3,380 | Common Stock |
| Biosig Technologies Inc | Steven Chaussy | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.39 per share. | 21 May 2021 | 1,000 | 832,128 (3%) | 0% | 3.4 | 3,390 | Common Stock |
| Biosig Technologies Inc | Steven Chaussy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 150,000 | 831,128 (3%) | 0% | 0 | Common Stock | |
| Biosig Technologies Inc | Steven Chaussy | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.35 per share. | 01 Dec 2020 | 2,000 | 681,128 (2%) | 0% | 4.3 | 8,699 | Common Stock |